Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604064 | PMC |
http://dx.doi.org/10.1093/ofid/ofae666 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!